Immix Biopharma, Inc. (IMMX)
NASDAQ: IMMX · Real-Time Price · USD
8.91
+0.24 (2.77%)
May 22, 2026, 9:43 AM EDT - Market open
Immix Biopharma Market Cap
Immix Biopharma has a market cap or net worth of $472.34 million as of May 22, 2026. Its market cap has increased by 700.55% in one year.
Market Cap
472.34M
Enterprise Value
370.07M
1-Year Change
700.55%
Ranking
Category
Stock Price
$8.91
Market Cap Chart
Since the IPO on December 16, 2021, Immix Biopharma's market cap has increased from $65.74M to $472.34M, an increase of 618.45%. That is a compound annual growth rate of 56.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 21, 2026 | 459.61M | 66.77% |
| Dec 31, 2025 | 275.60M | 355.41% |
| Dec 31, 2024 | 60.52M | -55.98% |
| Dec 29, 2023 | 137.48M | 331.07% |
| Dec 30, 2022 | 31.89M | -32.18% |
| Dec 31, 2021 | 47.02M | -28.48% |
| Dec 16, 2021 | 65.74M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Contineum Therapeutics | 500.98M |
| Ginkgo Bioworks Holdings | 496.47M |
| Climb Bio | 496.08M |
| Prothena Corporation | 485.58M |
| Achieve Life Sciences | 466.07M |
| Ocugen | 460.39M |
| vTv Therapeutics | 460.14M |
| Upstream Bio | 456.04M |